Literature DB >> 6873474

Active and passive immunization to protect against antibiotic associated caecitis in hamsters.

D S Fernie, R O Thomson, I Batty, P D Walker.   

Abstract

The administration of clindamycin to hamsters induces a lethal enterocolitis as a consequence of toxins produced in the alimentary tract by Clostridium difficile. The lethal and cytopathic effects of C. difficile toxins are neutralized in vitro by C. sordellii antitoxin and hamsters may be protected against clindamycin induction of caecitis by passive immunization using C. sordellii antitoxin. To examine active immunization using C. difficile and C. sordellii toxoids, groups of male and female Syrian hamsters were immunized on two occasions and challenged by parenteral clindamycin. A concentrated C. difficile toxoid protected 90% of females and 78% of males; the degree of protection per group decreased with dilution of the toxoid used for immunization. A similar degree of protection was observed in female hamsters immunized with a bivalent vaccine prepared from the partially purified toxins A and B of C. difficile. Immunization using a C. sordellii toxoid protected between 100 and 25% of females per group and between 50 and 12.5% of males per group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873474

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  23 in total

1.  Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate.

Authors:  D M Lyerly; E F Bostwick; S B Binion; T D Wilkins
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Clostridium difficile toxin A induces a specific antisecretory factor which protects against intestinal mucosal damage.

Authors:  J Torres; E Jennische; S Lange; I Lönnroth
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

3.  Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine.

Authors:  M Warny; A Fatimi; E F Bostwick; D C Laine; F Lebel; J T LaMont; C Pothoulakis; C P Kelly
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

4.  Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults.

Authors:  K L Kotloff; S S Wasserman; G A Losonsky; W Thomas; R Nichols; R Edelman; M Bridwell; T P Monath
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.

Authors:  D M Lyerly; C J Phelps; J Toth; T D Wilkins
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

6.  Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.

Authors:  J F Torres; D M Lyerly; J E Hill; T P Monath
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A.

Authors:  Tim Du; Michelle J Alfa
Journal:  Can J Infect Dis       Date:  2004-03

8.  Protective efficacy induced by recombinant Clostridium difficile toxin fragments.

Authors:  Rosanna Leuzzi; Janice Spencer; Anthony Buckley; Cecilia Brettoni; Manuele Martinelli; Lorenza Tulli; Sara Marchi; Enrico Luzzi; June Irvine; Denise Candlish; Daniele Veggi; Werner Pansegrau; Luigi Fiaschi; Silvana Savino; Erwin Swennen; Osman Cakici; Ernesto Oviedo-Orta; Monica Giraldi; Barbara Baudner; Nunzia D'Urzo; Domenico Maione; Marco Soriani; Rino Rappuoli; Mariagrazia Pizza; Gillian R Douce; Maria Scarselli
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

9.  Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.

Authors:  G Corthier; M C Muller; T D Wilkins; D Lyerly; R L'Haridon
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters.

Authors:  P H Kim; J P Iaconis; R D Rolfe
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.